Cogent Biosciences

We care. About our work, about our purpose, about our people.

It’s an exciting time to be part of Cogent Biosciences. In joining an early-stage public company, you will be a vital part of helping to achieve the Cogent vision. This is a place where your input matters and your work will help to drive our company and our science forward. You will have a direct influence on our programs and in shaping the capabilities of our team while helping foster the Cogent culture and be a part of a passionate, transparent, fast-moving, and collaborative work environment. You will have an impact.

At Cogent, we offer:

• A competitive compensation and benefits package
• Flexible work arrangements
• Virtual office support
• 401k match
• Free Parking & Conveniently located workout space (Cambridge site)
• Healthy snacks & wellness program
• Summer & Winter Shutdown
• Unlimited time off

Cogent’s office is in close proximity to leading academic institutions, hospitals, and the pharmaceutical and biotech ecosystem and community. This unique location allows for a high level of energy and intellectual exchange within and among fast growing early stage companies.

Cogent Biosciences is an organization built on innovation and dedication. We have assembled a stellar team of scientists and experts in drug discovery and development driven by a singular mission – to deliver best-in-class precision kinase inhibitors for patients with genetically defined diseases.

We are passionate, driven, collaborative, curious, and hard-working. If you thrive in a fast-paced environment and are excited by the opportunity to contribute to meaningful science and meaningful therapies for patients, join us!

This is only the beginning. We are building a drug discovery team to be based in Boulder, Colorado that will continue to deliver rationally designed precision therapies. We are actively searching for leaders in Medicinal Chemistry, Biology, and Pharmacology. Follow Cogent on LinkedIn for continued updates as we grow a team that will build a portfolio of new, selective, and potent precision medicines.